Fibrosis in chronic kidney disease: pathogenesis and consequences

S Panizo, L Martínez-Arias, C Alonso-Montes… - International journal of …, 2021 - mdpi.com
Fibrosis is a process characterized by an excessive accumulation of the extracellular matrix
as a response to different types of tissue injuries, which leads to organ dysfunction. The …

Chronic kidney disease—mineral and bone disorders: pathogenesis and management

JB Cannata-Andía, B Martín-Carro… - Calcified tissue …, 2021 - Springer
The key players of the chronic kidney disease-mineral and bone disorders (CKD-MBD) are
calcium, phosphate, PTH, FGF23, and the vitamin D hormonal system. The progressive …

Improvement of mineral and bone metabolism markers is associated with better survival in haemodialysis patients: the COSMOS study

JL Fernández-Martín… - Nephrology Dialysis …, 2015 - academic.oup.com
Background Abnormalities in serum phosphorus, calcium and parathyroid hormone (PTH)
have been associated with poor survival in haemodialysis patients. This COSMOS (Current …

[HTML][HTML] Use of phosphate-binding agents is associated with a lower risk of mortality

JB Cannata-Andía, JL Fernández-Martín, F Locatelli… - Kidney international, 2013 - Elsevier
Hyperphosphatemia has been associated with higher mortality risk in CKD 5 patients
receiving dialysis. Here, we determined the association between the use of single and …

Safety and efficacy of denosumab in osteoporotic hemodialysed patients

F Festuccia, MT Jafari, A Moioli, C Fofi, S Barberi… - Journal of …, 2017 - Springer
Background and aims In elderly subjects, renal insufficiency and osteoporosis often coexist
with high risk of fracture and elevated socio-economic burden. Today a large number of …

Systematic review and meta-analyses of the effects of phosphate-lowering agents in nondialysis CKD

NM Lioufas, EM Pascoe, CM Hawley… - Journal of the …, 2022 - journals.lww.com
Background Benefits of phosphate-lowering interventions on clinical outcomes in patients
with CKD are unclear; systematic reviews have predominantly involved patients on dialysis …

Targeting gastrointestinal transport proteins to control hyperphosphatemia in chronic kidney disease

D Fouque, M Vervloet, M Ketteler - Drugs, 2018 - Springer
Management of hyperphosphatemia in patients with dialysis-dependent chronic kidney
disease remains a major challenge, requiring a multifaceted approach that includes dietary …

Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients

P Barrera-Baena, M Rodríguez-García… - Nephrology Dialysis …, 2024 - academic.oup.com
Background Bone fragility fractures are associated with high morbidity and mortality. This
study analysed the association between the current biochemical parameters of chronic …

Distribution, preparedness and management of Ukrainian adult refugees on dialysis—an international survey by the Renal Disaster Relief Task Force of the European …

E Pawłowicz-Szlarska, R Vanholder… - Nephrology Dialysis …, 2023 - academic.oup.com
ABSTRACT Background Due to the Russian–Ukrainian war, some of the about 10 000
adults requiring dialysis in Ukraine fled their country to continue dialysis abroad. To better …

Vitamin D deficiency—prognostic marker or mortality risk factor in end stage renal disease patients with diabetes mellitus treated with hemodialysis—a prospective …

A Schiller, F Gadalean, O Schiller, R Timar, F Bob… - Plos one, 2015 - journals.plos.org
Background End stage renal disease (ESRD) patients on renal replacement therapy (RRT)
with diabetes mellitus (DM) have a higher mortality rate and an increase prevalence of …